Clinical Chemistry

Papers
(The TQCC of Clinical Chemistry is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform306
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020237
Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads178
Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification160
Clinical Performance of Two SARS-CoV-2 Serologic Assays158
Inflammation in Atherosclerosis—No Longer a Theory153
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease129
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation116
Limits of Detection of 6 Approved RT–PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)106
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays106
Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Contro100
Lipoprotein(a) and Cardiovascular Disease100
Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity96
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies95
Rapid Detection of SARS-CoV-2 by Low Volume Real-Time Single Tube Reverse Transcription Recombinase Polymerase Amplification Using an Exo Probe with an Internally Linked Quencher (Exo-IQ)94
SARS-CoV-2 Serology: Much Hype, Little Data83
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning75
Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and Diagnosis68
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Cl65
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test62
Metagenomic Analysis Reveals Clinical SARS-CoV-2 Infection and Bacterial or Viral Superinfection and Colonization61
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay58
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group58
The Role of Metagenomics and Next-Generation Sequencing in Infectious Disease Diagnosis56
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease55
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections53
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-251
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaborati48
Antibody Profiles in Mild and Severe Cases of COVID-1948
Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation46
Lateral Flow Assays in Infectious Disease Diagnosis45
Cautionary Note on Contamination of Reagents Used for Molecular Detection of SARS-CoV-245
Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation44
Myocardial Injury and the Release of Troponins I and T in the Blood of Patients43
The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-1940
Efficiency Correction Is Required for Accurate Quantitative PCR Analysis and Reporting40
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test39
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?38
Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)37
Identifying and Quantifying Cannabinoids in Biological Matrices in the Medical and Legal Cannabis Era37
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection36
Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis35
SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-1935
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer34
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer33
Fragment Size Analysis May Distinguish Clonal Hematopoiesis from Tumor-Derived Mutations in Cell-Free DNA33
Detection of ctDNA from Dried Blood Spots after DNA Size Selection32
Noninvasive Fetal Genotyping by Droplet Digital PCR to Identify Maternally Inherited Monogenic Diabetes Variants32
Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions31
SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission29
Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism29
Understanding Patient-Based Real-Time Quality Control Using Simulation Modeling29
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study29
Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice28
Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues28
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population28
Navigating Clinical Utilization of Direct-from-Specimen Metagenomic Pathogen Detection: Clinical Applications, Limitations, and Testing Recommendations27
Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elev27
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance26
High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-1926
Molecular and Serological Assays for SARS-CoV-2: Insights from Genome and Clinical Characteristics26
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application o26
Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing25
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID25
Characteristics of Fetal Extrachromosomal Circular DNA in Maternal Plasma: Methylation Status and Clearance25
Performance of a Paired-End Sequencing-Based Noninvasive Prenatal Screening Test in the Detection of Genome-Wide Fetal Chromosomal Anomalies25
Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples25
Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Perf24
Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation24
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study24
Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals23
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow23
Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy23
Preparedness and Rapid Implementation of External Quality Assessment Helped Quickly Increase COVID-19 Testing Capacity in the Republic of Korea23
Artificial Intelligence and Mapping a New Direction in Laboratory Medicine: A Review23
Genomic Prediction of Antimicrobial Resistance: Ready or Not, Here It Comes!23
Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis23
Jagged Ends of Urinary Cell-Free DNA: Characterization and Feasibility Assessment in Bladder Cancer Detection23
Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts23
Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study23
The Truth about SARS-CoV-2 Cycle Threshold Values Is Rarely Pure and Never Simple22
99th Percentile Upper-Reference Limit of Cardiac Troponin and the Diagnosis of Acute Myocardial Infarction22
Analytical Sensitivity and Specificity of Four Point of Care Rapid Antigen Diagnostic Tests for SARS-CoV-2 Using Real-Time Quantitative PCR, Quantitative Droplet Digital PCR, and a Mass Spectrometric 21
Standardized Workflow for Precise Mid- and High-Throughput Proteomics of Blood Biofluids21
Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP21
Biological Variation of Cardiac Troponins in Health and Disease: A Systematic Review and Meta-analysis20
Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role?20
IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure20
Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study20
Nanopore Identification of Single Nucleotide Mutations in Circulating Tumor DNA by Multiplexed Ligation20
Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results20
Comprehensive Analysis of Congenital Adrenal Hyperplasia Using Long-Read Sequencing20
Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study19
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients19
AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories19
A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic19
SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing19
How Can We Ensure Reproducibility and Clinical Translation of Machine Learning Applications in Laboratory Medicine?19
25-Hydroxyvitamin D and Risk of Osteoporotic Fractures: Mendelian Randomization Analysis in 2 Large Population-Based Cohorts19
Plasma S100A8/A9 Concentrations and Clinical Outcomes of Ischemic Stroke in 2 Independent Multicenter Cohorts19
Development of a Plasma Biomarker Diagnostic Model Incorporating Ultrasensitive Digital Immunoassay as a Screening Strategy for Alzheimer Disease in a Chinese Population18
Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification18
Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome18
Cell-Free DNA as Biomarker for Sepsis by Integration of Microbial and Host Information18
Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine18
Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging18
Regression-Adjusted Real-Time Quality Control17
Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients17
Analytical Performance Specifications for Lipoprotein(a), Apolipoprotein B-100, and Apolipoprotein A-I Using the Biological Variation Model in the EuBIVAS Population17
RIbench: A Proposed Benchmark for the Standardized Evaluation of Indirect Methods for Reference Interval Estimation17
Cell-Free DNA Fragmentomics: The New “Omics” on the Block17
Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure17
Development of Label-Free Immunoassays as Novel Solutions for the Measurement of Monoclonal Antibody Drugs and Antidrug Antibodies17
Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies17
Metabolomics in Clinical Practice: Improving Diagnosis and Informing Management16
Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review16
The Vitamin D Metabolite Ratio Is Independent of Vitamin D Binding Protein Concentration16
Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine16
Choice of Statistical Tools for Outlier Removal Causes Substantial Changes in Analyte Reference Intervals in Healthy Populations16
Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity16
Diagnostic Performance of Metagenomic Next-Generation Sequencing in Pediatric Patients: A Retrospective Study in a Large Children’s Medical Center16
Overinterpretation of Research Findings: Evaluation of “Spin” in Systematic Reviews of Diagnostic Accuracy Studies in High–Impact Factor Journals15
Single-Cell Identification, Drug Susceptibility Test, and Whole-genome Sequencing of Helicobacter pylori Directly from Gastric Biopsy by Clinical Antimicrobial Susceptibility Test Ramanometry15
Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression15
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers15
Circular RNA Sequencing Reveals Serum Exosome Circular RNA Panel for High-Grade Astrocytoma Diagnosis15
Glycated Albumin for the Diagnosis of Diabetes in US Adults15
Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability15
Very Low-Density Lipoprotein Cholesterol May Mediate a Substantial Component of the Effect of Obesity on Myocardial Infarction Risk: The Copenhagen General Population Study15
Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay forPD-L1Transcripts in Circulating Tumor Cells15
The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation14
Mass Spectrometry for COVID-1914
Sample Multiplexing: Increased Throughput for Quantification of Total Testosterone in Serum by Liquid Chromatography-Tandem Mass Spectrometry14
Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM)14
Biomarkers and Clinical Laboratory Detection of Acute and Chronic Ethanol Use14
ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease14
High-Throughput CRISPR–Cas13 SARS-CoV-2 Test14
HDL in Morbidity and Mortality: A 40+ Year Perspective14
Recent Advances in Rapid Antimicrobial Susceptibility Testing14
A Collaborative Effort to Define Classification Criteria forATMVariants in Hereditary Cancer Patients14
Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma14
Biomarkers for Risk Assessment in Atrial Fibrillation14
The European Biological Variation Study (EuBIVAS): Biological Variation Data for Coagulation Markers Estimated by a Bayesian Model14
Achieving Expert-Level Interpretation of Serum Protein Electrophoresis through Deep Learning Driven by Human Reasoning13
What Is Extrachromosomal Circular DNA and What Does It Do?13
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)13
Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) Study13
Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure13
Interoperability: COVID-19 as an Impetus for Change13
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure13
Empiricism in Microsampling: Utilizing a Novel Lateral Flow Device and Intrinsic Normalization to Provide Accurate and Precise Clinical Analysis from a Finger Stick13
Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse13
Evaluation of Sperm DNA Integrity by Mean Number of Sperm DNA Breaks Rather Than Sperm DNA Fragmentation Index13
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring13
Long-Term Longitudinal Stability of Kidney Filtration Marker Measurements: Implications for Epidemiological Studies and Clinical Care12
Glycated Albumin and Risk of Mortality in the US Adult Population12
Early Rule-Out Strategies in the Emergency Department Utilizing High-Sensitivity Cardiac Troponin Assays12
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients12
Data Mining Approaches to Reference Interval Studies12
Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein–Barr Virus–Positive Nasopharyngeal Carc12
Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test12
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer12
Breath Metabolites to Diagnose Infection12
Current State of Laboratory Automation in Clinical Microbiology Laboratory12
Diagnostic Stewardship in Clinical Microbiology, Essential Partner to Antimicrobial Stewardship11
TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability11
Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests11
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform11
Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis11
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma11
Sex-Specific Kinetics of High-Sensitivity Cardiac Troponin I and T following Symptom Onset and Early Presentation in Non-ST-Segment Elevation Myocardial Infarction11
Multiplex PCR and Nanopore Sequencing of Genes Associated with Antimicrobial Resistance in Neisseria gonorrhoeae Directly from Clinical Samples11
Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study11
Laboratory-Developed Tests in the New European Union 2017/746 Regulation: Opportunities and Risks11
Cardiac Biomarkers in Pediatrics: An Undervalued Resource11
Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders11
Enhanced Performance of DNA Methylation Markers by Simultaneous Measurement of Sense and Antisense DNA Strands after Cytosine Conversion11
Type I Interferon in Children with Viral or Bacterial Infections11
Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer11
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study10
A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making10
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial10
Relative Efficacy of Different Strategies for Inhibition of in Vitro Glycolysis10
Prognostic Metrics Associated with Inflammation and Atherosclerosis Signaling Evaluate the Burden of Adverse Clinical Outcomes in Ischemic Stroke Patients10
Diagnostic Validation of a High-Sensitivity Cardiac Troponin I Assay10
An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond10
Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles10
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma10
Metabolomic Fingerprints in Large Population Cohorts: Impact of Preanalytical Heterogeneity10
Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study10
Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia9
Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling9
Neutral-Coating Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Top-Down Identification of Hemoglobin Variants9
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review9
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden9
LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial9
Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations9
Ultrasensitive DNA Immune Repertoire Sequencing Using Unique Molecular Identifiers9
Next-Generation Sequencing–Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients9
Direct Water-Assisted Laser Desorption/Ionization Mass Spectrometry Lipidomic Analysis and Classification of Formalin-Fixed Paraffin-Embedded Sarcoma Tissues without Dewaxing9
Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes9
Identifying Clinically Relevant Bacteria Directly from Culture and Clinical Samples with a Handheld Mass Spectrometry Probe9
Microbial Taxonomy: How and Why Name Changes Occur and Their Significance for (Clinical) Microbiology9
Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management9
Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results9
Effect of Macrotroponin in a Cohort of Community Patients with Elevated Cardiac Troponin9
High Speed Centrifugation Before Frozen Storage of Plasma Is Critical for Quantitative Analysis of Mitochondrial-Derived Cell-Free DNA9
Digital Quantification of Chemical Oligonucleotide Synthesis Errors9
Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern9
Uncertainty in Estimated Glomerular Filtration Rate Is Much Larger than the Race Adjustment Term9
Elementary Overview of Heavy Metals9
Patient-Based Real Time QC9
Deep Convolutional Neural Networks Implementation for the Analysis of Urine Culture9
Comprehensive Analysis of Fragile X Syndrome: Full Characterization of the FMR1 Locus by Long-Read Sequencing9
A Machine Learning Approach for the Automated Interpretation of Plasma Amino Acid Profiles8
High-Sensitivity Single Molecule Array Assays for Pathological Isoforms in Parkinson’s Disease8
Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia8
CRISPR Cas9-Mediated Selective Isothermal Amplification for Sensitive Detection of Rare Mutant Alleles8
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking8
Use of Racial and Ethnic Categories in Medical Testing and Diagnosis: Primum Non Nocere8
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use8
Cardiovascular Disease in Women: Understanding the Journey8
Average of Patient Deltas: Patient-Based Quality Control Utilizing the Mean Within-Patient Analyte Variation8
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma8
Challenges in Translating Clinical Metabolomics Data Sets from the Bench to the Bedside8
Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection8
Plasma Concentrations of Magnesium and Risk of Dementia: A General Population Study of 102 648 Individuals8
Interpreting EQA—Understanding Why Commutability of Materials Matters8
Guidance on Which Calibrators in a Metrologically Traceable Calibration Hierarchy Must Be Commutable with Clinical Samples8
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer8
Applications of Digital Microscopy and Densely Connected Convolutional Neural Networks for Automated Quantification of Babesia-Infected Erythrocytes8
Plasma Clearance of B-Type Natriuretic Peptide (BNP) before and after Bariatric Surgery for Morbid Obesity8
Combining First and Second-Tier Newborn Screening in a Single Assay Using High-Throughput Chip-Based Capillary Electrophoresis Coupled to High-Resolution Mass Spectrometry8
Recognition of the Prehospital Preanalytical Phase: Collaborative Efforts between Laboratory Medicine and Emergency Medicine to Ensure Quality Testing8
Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies8
Clinical Decision Support for Laboratory Testing8
Erratum: The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 20208
Measurement of Immature Reticulocytes in Dried Blood Spots by Mass Spectrometry7
Sex-Specific 99th Percentile URLs for Cardiac Troponin Assays—Their Time Has Come7
Optimized Droplet Digital PCR Assay on Cell-Free DNA Samples for Non-Invasive Prenatal Diagnosis: Application to Beta-Thalassemia7
At-Home Testing for Infectious Diseases: The Laboratory Where You Live7
Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory7
Error Characterization and Statistical Modeling Improves Circulating Tumor DNA Detection by Droplet Digital PCR7
Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay’s Limit of Detection?7
Improving Harmonization and Standardization of Expanded Newborn Screening Results by Optimization of the Legacy Flow Injection Analysis Tandem Mass Spectrometry Methods and Application of a Standardiz7
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer7
Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases7
Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly7
Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays7
A Three-Site Immunoassay for High-Sensitivity Cardiac Troponin I with Low Immunoreactivity for Macrocomplexes7
0.024723052978516